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Most species of plants and animals synthesize ascorbic acid, but human subjects cannot, making
vitamin C an essential component of our diet. Relationships between vitamin C intake and status,
and between status and health are not yet clear. There is evidence, however, that higher intake of
vitamin C is associated with lower risk of disease, supporting the concept that optimal intake is
needed for optimal vitamin C status, and that both factors are required for optimal health. Vitamin
C has low toxicity in healthy subjects, but a clear definition of optimal status and the dietary intake
required to meet and maintain this status is needed before a change in the current recommended
intake can be considered. Available evidence suggests that intake of 200 mg vitamin C/d saturates
tissues and maintains fasting plasma levels above the proposed threshold (50 µmol/l) for minimum
risk of CHD. However, the issue of whether or not these levels produce ‘optimal vitamin C status’
awaits the clear and accepted definition of the term. This definition in turn awaits the development
of reliable functional markers capable of assessing the effects of varying levels of vitamin C
nutriture. In the present paper the relationship between intake and body stores of vitamin C and
the role of vitamin C in human health are reviewed briefly. The requirements of a reliable
functional marker of human vitamin C status are defined, three classes of functional markers
(molecular, biochemical and physiological) are described, and possible candidate markers are
examined.
Vitamin C: Ascorbic acid: Antioxidants: Micronutrient status: Functional marker
Vitamin C comprises two biologically-active vitamers,
L-ascorbic acid and its two-electron reduction product
dehydro-L-ascorbic acid. Most species of plants and animals
synthesize ascorbic acid from glucose, but human subjects
cannot, making vitamin C an essential dietary component
(Levine, 1986; Padh, 1990). Relationships between vitamin
C intake and status, and between status and health are not
yet clear (Hennekens et al. 1994; Weber et al. 1996;
Halliwell, 1997; Hemila, 1997; Strain & Benzie, 1998).
There is evidence, however, that higher intake of vitamin C
is associated with lower risk of disease (Block, 1991;
Diplock, 1994; Riemiersma, 1994; Bendich & Langseth,
1995; Gey, 1995; Machlin, 1995; Benzie, 1998), supporting
the concept that optimal intake is needed for optimal vitamin
C status, and that both are required for optimal health
(Levine & Hartzell, 1987; Halliwell, 1996). Vitamin C has
low toxicity in healthy subjects (Diplock, 1994; Hathcock,
1997), but a clear definition of optimal status, and the
dietary intake required to meet and maintain this status, is
needed before a change in the current recommended intake
can be considered (Young, 1996). However, assessing
vitamin C status is problematic, and there are currently no
established functional markers of status. In the present paper
the relationship between intake and body stores of vitamin
C, and the role of vitamin C in human health are reviewed
briefly, and the requirements of a reliable functional marker
of human vitamin C status and possible candidate markers
are examined.
Vitamin C status: relationship between intake and body 
stores
In simple terms, vitamin C status describes the amount of
vitamin C within target tissues and fluids. Status reflects the
balance between various factors controlling supply and
turnover of the vitamin (Fig. 1). These controlling factors
are far from constant and are difficult to assess. In terms of
supply, vitamin C is destroyed during storage, processing
and cooking of foods, and by interaction with other dietary
components (Halliwell, 1996; Bates, 1997). Thus, estimates
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of dietary intake may be approximate at best. In human
subjects absorption and distribution of vitamin C are gener-
ally assessed by measurement of vitamin C concentrations
in easily-sampled biological fluids and tissues, largely
limiting investigation to blood and urine. Saliva can be used,
but levels are low and do not correlate with plasma levels
(Jacob et al. 1987). Vitamin C is not bound to protein, and is
lost in urine when plasma concentrations exceed the urinary
re-absorption threshold of about 85 µmol/l (Kallner et al.
1981; Schorah, 1992; Levine et al. 1993). However, urinary
vitamin C concentration is insensitive and unreliable as a
marker of vitamin C status. For example, no urinary loss
of vitamin C was seen following intake of ≤ 30 mg,
but occurred in all subjects following intake of 100 mg
(Graumlich et al. 1997), implying that detectable vitamin C
in urine indicates adequate intake. An earlier study
(Blanchard et al. 1990), however, reported continued
urinary loss of vitamin C in depleted men taking < 10 mg/d.
In health the concentration of vitamin C in fasting plasma
is 25–80 µmol/l (Evans et al. 1982; Frei et al. 1989;
Blanchard et al. 1990; Benzie et al. 1998). Virtually all
vitamin C in the circulating plasma is in the reduced form,
ascorbic acid (Levine et al. 1993). There appears to be rapid
uptake by erythrocytes of dehydro-L-ascorbic acid formed
within the circulation, dehydro-L-ascorbic acid being imme-
diately reduced to ascorbic acid by intracellular GSH
(Mendiratta et al. 1998). Plasma ascorbic acid levels are
reported to be lower in men than in women and to decrease
with age (Garry et al. 1987; Blanchard et al. 1990; Bailey
et al. 1997), but there is no clear physiological rationale
for these differences, and they are not always found
(Benzie et al. 1998). Plasma ascorbic acid concentrations
peak at 1–2 h after ingestion, and response is related to the
dose but not to the fasting plasma concentration (Benzie &
Strain, 1997a). However, the relative amount absorbed
decreases as the dose increases (Mayersohn, 1972; Kallner
et al. 1981; Melethil et al. 1986; Levine et al. 1993; Benzie
& Strain, 1997a). The upper limit of plasma ascorbic acid
concentration is controlled by the gastrointestinal absorption
and renal re-absorption mechanisms, and fasting plasma
concentrations rarely exceed 100 µmol/l, even with dietary
supplementation (Graumlich et al. 1997); however, follow-
ing a large (≥ 500 mg) oral dose plasma levels can increase
several fold, and may approach 200 µmol/l (Benzie &
Strain, 1997a; Fig. 2).
Intracellular vitamin C levels can exceed eighty times
that of plasma (Evans et al. 1982). At stable intakes, vitamin
C concentrations in fasting plasma correlate directly and
significantly with platelet, erythrocyte and leucocyte
concentrations (Jacob et al. 1987; Levine et al. 1995;
Graumlich et al. 1997), and fasting plasma concentrations of
> 60 µmol ascorbic acid/l indicate tissue saturation
(Graumlich et al. 1997). However, there is no established
plasma threshold defining deficiency, and plasma ascorbic
acid concentrations of > 11·4, > 17, and > 22·7 µmol/l have
been regarded as acceptable (see Ortega et al. 1998). In
depletion studies of healthy young men plasma vitamin C
concentrations decreased to an average of 7 µmol/l without
clinical signs of scurvy (Jacob et al. 1987; Graumlich et al.
1997). However, clinical signs indicate the late stage of
chronic and severe deficiency. Moreover, it is likely that
demand for vitamin C in the study populations of young
healthy non-smoking and otherwise well-nourished men
was low. In contrast, demand may be high in certain
situations or disorders. Pregnancy, smoking, inflammation,
diabetes mellitus and pre-eclampsia increase the input
Fig. 1. Factors controlling vitamin C status. GI, gastrointestinal tract.
Fig. 2. Plasma ascorbic acid response to ingestion of vitamin C;
peak post-ingestion (v) and fasting (r) levels at different intakes of
vitamin C. Points are mean values and standard deviations repre-
sented by vertical bars. (From Benzie & Strain, 1997a; Graumlich et
al. 1997.)
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required to maintain ‘normal’ plasma levels (Schorah, 1992;
Smirnoff & Pallanca, 1996; Bates, 1997; Halliwell, 1997;
Hubel et al. 1997); exercise, environmental pollution,
plasma concentrations of vitamin E, uric acid and glucose
also influence vitamin C metabolism (Levine, 1986;
Schorah, 1992; Benzie & Strain, 1996a; Marangon et al.
1998). Thus, plasma levels may indicate functional
reserves of vitamin C but may not reflect functional
status; functional markers of vitamin C status are needed
for this.
Measurement of vitamin C can also be problematic in
analytical terms, as most simple methods of measurement
are non-specific. Sensitive and specific methods are availa-
ble (Bates et al. 1994; Benzie, 1996a); however, vitamin C
is rapidly destroyed ex vivo, particularly at alkaline pH and
in the presence of transition metal ions (Buettner &
Jurkiewicz, 1996). Thus, special handling of samples is
required, with acid stabilization of ascorbic acid before
storage at low temperature, or immediate testing of the
sample (Bates et al. 1994; Benzie, 1996a).
Stable-isotope studies using 13C-labelled ascorbic acid
and GC-mass spectrometry (Bluck et al. 1996) offer a
powerful means of monitoring distribution and turnover of
vitamin C in vivo. This highly sophisticated and demanding
technique is still, however, in the developmental stage.
Currently, therefore, and despite its limitations, measure-
ment of fasting plasma ascorbic acid concentration is the
most commonly used method of assessing vitamin C status.
Vitamin C and health
The reference nutrient intake of 40 mg/d (Department of
Health, 1991) is aimed at prevention of the clinical
deficiency state, scurvy (Bates, 1997). However, no obvious
deficiency does not necessarily indicate adequacy (Levine
et al. 1995), and subclinical or marginal deficiency of
vitamin C owing to insufficient intake and/or to increased
utilization may be common. The wide range of signs and
symptoms of scurvy indicate the many and varied metabolic
systems with which vitamin C interacts. These systems
include collagen synthesis, steroid and peptide metabolism,
endocrine function, the immune system, blood pressure
control, haemostasis, Fe and Cu balance and mitochondrial
fatty acid catabolism (Levine, 1986; Padh, 1990; Smirnoff
& Pallanca, 1996; Bates, 1997; Hemila, 1997). However,
while the systems themselves are diverse, the biochemical
role played by vitamin C in each system appears to be
mediated via its antioxidant properties (Frei et al. 1989;
Padh, 1990).
Increased risk of chronic disease, including cancer,
cataracts and CHD, is associated with low intake or plasma
concentrations of vitamin C (Block, 1991; Riemiersma,
1994; Gey, 1995; Machlin, 1995; Maxwell & Lip, 1997;
Benzie, 1998). Supplementation with vitamin C is reported
to decrease blood pressure and blood lipids, improve
glucose metabolism and endothelial function, and to
increase resistance of lipids and DNA to oxidative damage
(Paolisso et al. 1994; Benzie, 1996b; Frei et al. 1996;
Halliwell, 1996; Levine et al. 1996; Weber et al. 1996;
Sweetman et al. 1997). However, the contribution of high
intake or plasma levels of vitamin C to lowered risk of
disease is difficult to assess, as other health-promoting hab-
its generally accompany high vitamin C intake, and clinical
trials have shown inconsistent and inconclusive results
(Hennekens et al. 1994; Halliwell, 1997; Benzie, 1998).
Nonetheless, based on results of depletion–repletion and
observational studies, an optimal vitamin C intake of
200 mg/d (Graumlich et al. 1997) and a threshold ‘potential
protective plasma level’ of 50 µmol/1 (Gey, 1995) have
been proposed. These values have yet to be endorsed in
terms of increased reference nutrient intake, as changes in
nutritional public policy require that unequivocal benefit ‘in
terms of health-related outcomes’ of increased vitamin C
intake is established (Young, 1996; Blanchard et al. 1997;
Halliwell, 1997; Shane, 1997). Results of long-term vitamin
C supplementation studies will resolve the question of
whether the reference nutrient intake should be changed,
but such studies are costly and time-consuming. Reliable
functional markers of vitamin C status could serve as early
surrogate health-related end points, providing information to
help plan and monitor clinical trials while helping to guide
more immediate nutritional requirements.
Functional markers of vitamin C status: criteria and 
prospects
Diet controls but does not completely define body stores of
vitamin C, and demand may outstrip an apparently-adequate
supply. Fasting plasma levels of ascorbic acid reflect but do
not equate to body stores, and there may be islands of need
within oceans of plenty. In order to define and differentiate
between optimal, adequate, marginal, inadequate and
deficient categories of vitamin C status, reliable markers of
vitamin C function are needed (King, 1996; Young, 1996;
Bates, 1997). Such markers will complement methods of
assessing intake, distribution and body stores, and help map
links between the immediate effects and eventual outcome
of different levels of vitamin C nutriture.
A reliable functional marker of micronutrient status in
human subjects must:
respond sensitively, specifically and predictably to
changes in the concentration and/or supply of the micro-
nutrient, i.e. there must be a measurable dose–response
relationship;
be accessible for measurement, i.e. the marker must be
present in body fluids or cells which can be sampled or
imaged in some way;
be in a form and quantity which can be measured
objectively and reproducibly, i.e suitable analytical
tools and methods must be available;
reflect a change in the target tissue or fluid which has a
direct impact on health, i.e. must relate to a physio-
logical or pathological end point.
Vitamin C acts on various biological systems, and while
no single specific marker of vitamin C function has been
identified, three classes of functional markers can be
described:
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(1) molecular markers which relate to effects on function or
activity of specific molecules; these effects are likely to
be mediated directly by vitamin C;
(2) biochemical markers which relate to effects on levels of
biochemical constituents in body fluids; these effects
are likely to be the result of molecular changes;
(3) physiological (biological) markers which relate to
effects on homeostatic processes or organ systems
resulting in physiological (or pathological) change;
these effects are likely to be the result of biochemical
changes.
Molecular markers
Specificity and sensitivity can be high for this class of
marker which relates to, for example, oxidative changes in
enzymes. Ascorbic acid affects the activity of at least ten
oxidoreductase or hydroxylating Fe- or Cu-containing
enzymes, including dopamine-β-monooxygenase (EC
1.14.17.1; Levine & Hartzell, 1987; Ginter, 1989; Padh,
1990). This Cu-containing enzyme is involved in noradrena-
line biosynthesis and, while there is no absolute requirement
for vitamin C, ascorbic acid is a specific and dose-dependent
enhancer of enzyme activity. Conceptually, this marker
meets the first requirement, and in theory vitamin C func-
tional status could be assessed by measuring the rate of
noradrenaline production by target cells. However, sam-
pling these cells (chromaffin cells from the adrenal medulla)
is not a practical option in human subjects, and the ascorbic
acid-related enzyme kinetics reportedly differ depending on
whether the enzyme is isolated or in situ (Levine & Hartzell,
1987). In addition, there is no evidence that ascorbic acid-
dependent maximum activity of this enzyme is required for
health, questioning its use as a functional marker (Young,
1996).
The activities of two hepatic enzyme systems, cholesterol
7α-monooxygenase (EC 1.14.13.17) and the microsomal
cytochrome P450 detoxification system, may be useful
functional markers of vitamin C status (Ginter, 1989). These
enzymes are also dependent on vitamin C for maximal
activity, and in human subjects this may be optimal for
cholesterol metabolism and detoxification of xenobiotics.
While perhaps sensitive and specific, and related directly to
health, these intracellular markers of vitamin C function are,
however, difficult to access and evaluate. Their biochemical
effects in terms of cholesterol concentration and detox-
ification can be measured, but cannot be related specifically
to vitamin C status.
Mitochondrial glycerol-3-phosphate dehydrogenase (EC
1.1.1.8) is needed for glucose-coupled ATP-dependent
insulin release from pancreatic B cells, and in guinea-pig tis-
sue ascorbic acid is needed as a stimulatory cofactor
(Jung & Wells, 1997). This role could help explain the
modulating effect of vitamin C on B cell function and
glucose homeostasis (Paolisso et al. 1994). More effective
insulin response to a glucose load after vitamin C supple-
mentation was reported in a study of idiopathic Ca stone-
formers (Swille et al. 1997) and, therefore, study of pre- and
post-vitamin C supplementation insulin sensitivity could be
a useful, although currently speculative, functional marker
of status.
Ascorbic acid has been reported to prevent NADPH-
initiated free Fe-independent cytochrome P450-dependent
microsomal lipid peroxidation (Ghosh et al. 1997). This
specific inhibition is thought to be mediated by the reaction
of ascorbic acid with the perferryl radical form of cyto-
chrome P450 (P450Fe3+O·−). Ascorbic acid neutralizes the
perferryl radical and prevents abstraction of H from a
polyunsaturated fatty acid. In studies of guinea-pigs it was
reported that lipid peroxidation occurred in association with
ascorbic acid deficiency, even at subclinical levels and
despite adequate amounts of other antioxidants such as
vitamin E and GSH (Ghosh et al. 1997). This effect of
ascorbic acid is related directly to health, as lipid peroxida-
tion increases atherogenesis and risk of CHD (Steinberg
et al. 1989; Machlin, 1995; Benzie, 1996b; Maxwell & Lip,
1997), but has yet to be demonstrated in human subjects.
Currently, the use of molecular markers is restricted
owing to the invasive nature of obtaining the tissue samples
required, and to the lack of suitable analytical or imaging
tools. Future studies of molecular markers may target DNA
mutagenesis and cytokines, adhesion molecules, heat-shock
proteins and other gene products regulated by the redox state
of the cell (Jackson et al. 1998; Reilly et al. 1998). These
tests may prove to be very sensitive indicators of oxidative
change; however, their specificity in relation to vitamin C
status is questionable.
Biochemical markers
Currently these markers offer a more practical option than
molecular markers. However, biochemical changes are
removed from the direct action of ascorbic acid, and indeed
the direct effect may be unknown. This factor lowers their
specificity and sensitivity in relation to vitamin C function.
Ascorbic acid is a cofactor in the biosynthesis of
carnitine, which is required in the cytosolic–mitochondrial
transfer of fatty acids (Feller & Ridman, 1988). Lack of
carnitine could account for the weakness and fatigue experi-
enced in scurvy. However, results of human studies have not
shown the anticipated decrease in plasma carnitine with low
vitamin C intake, and one study of marginally-deficient
subjects reported an inverse relationship between plasma
ascorbic acid and free carnitine concentrations, perhaps due
to impaired carnitine transport (Johnston et al. 1996).
Excretion of carnitine has been reported to be increased in
vitamin C deficiency, and a significant inverse correlation
(r −0·727; P < 0·05) between leucocyte ascorbic acid
concentrations and 24 h urinary carnitine was reported in
eight healthy men given different amounts of vitamin C over
13 weeks (Jacob & Pianalto, 1997). Increased excretion of
carnitine did not appear to compromise carnitine status, at
least within the time frame of the study, and it was
concluded that plasma carnitine measurements did not offer
a useful functional measure of human vitamin C status.
Nevertheless, the fairly strong inverse correlation seen
between mononuclear leucocyte vitamin C concentrations
and carnitine excretion is interesting, and measurement of
free carnitine may offer a more sensitive index of vitamin C
status (Johnston et al. 1996).
Vitamin C deficiency has a well-established consequence
in altered collagen metabolism (Bates et al. 1972). Collagen
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is rich in hydroxyproline, and changes in hydroxyproline
have been investigated as an index of vitamin C-related
collagen turnover (Bates, 1977; Johnston et al. 1985; Hevia
et al. 1990). One study showed an inverse relationship
between leucocyte ascorbic acid levels and hydroxyproline
excretion, but only in women (Bates, 1977). However, a
study of eleven men receiving low, normal and high vitamin
C intakes over 14 weeks reported significant inverse correla-
tions between ascorbic acid concentrations in plasma,
erythrocytes and leucocytes, and 24 h hydroxyproline
excretion (Hevia et al. 1990). Hydroxyproline excretion
decreased significantly within a few days of change from
low (5 mg/d) to high (375 mg/d) vitamin C intake. However,
hydroxyproline excretion was the same at moderate
(65 mg/d) and high (605 mg/d) intakes of vitamin C and
inter-individual responses were variable. Hydroxyproline
excretion is not, therefore, a sensitive marker of mild
vitamin C deficiency (Hevia et al. 1990).
A potentially-powerful biochemical marker is deoxy-
pyridinoline : pyridinoline collagen cross-links (Tsuchiya &
Bates, 1997). Deoxypyridinoline synthesis requires lysine,
while synthesis of pyridinoline requires hydroxylysine.
Ascorbic acid is a cofactor for the hydroxylation of lysyl- to
hydroxylysyl- residues in collagen. Vitamin C deficiency is
known to affect the hydroxylation of lysine, inducing a lack
of hydroxylysine for pyridinoline cross-linking (Bates et al.
1972). Thus, in suboptimal vitamin C status an increase in
lysine-derived collagen cross-links might be expected. A
study in guinea-pigs showed that deoxypyridinoline (lysine-
derived) : total collagen cross-links in the femur shafts of
animals fed on an ‘adequate’ ascorbic acid diet was virtually
twofold that of animals on a high-ascorbic acid diet
(Tsuchiya & Bates, 1997; Fig. 3). The same pattern, though
less pronounced, was seen in urine. This potential functional
marker meets the requirements of sample (urine) access-
ibility, suitable analytical tools are available, and there is a
clear health-related link. However, questions of sensitivity
and specificity remain, and human dose–response studies
have yet to be reported.
Ascorbic acid is a physiological antioxidant of major
importance (Frei et al. 1989), and contributes up to 24 % of
the ‘total antioxidant power’ of plasma (Wayner et al. 1987;
Benzie & Strain, 1996b). Measuring the absolute and
relative contributions of ascorbic acid to the total anti-
oxidant power of biological fluids could be a useful marker
of reserve for this defensive role (Benzie & Strain, 1997b).
A more functional approach is the measurement of the
ascorbate free radical (Hubel et al. 1997). Increased levels
of ascorbate free radical may indicate increased oxidative
turnover of ascorbic acid and therefore, ascorbate free
radical : ascorbic acid may be a useful marker of vitamin C
antioxidant utilization or function.
Other potential markers of the antioxidant function of
vitamin C relate to lack of effect. Ascorbic acid is the only
scavenging antioxidant which can prevent initiation of lipid
peroxidation (Frei et al. 1996). Thus, lipid peroxides in
biological fluids could act as a sign of inadequate vitamin C
status. While commonly-used methods of measuring lipid
peroxides are insensitive and non-specific (Benzie, 1996b),
recently-developed methods such as the measurement of F2
isoprostanes by HPLC and the flow cytometric analysis of
lipid peroxidation in cell membranes (Roberts & Morrow,
1994; Makrigiorgos et al. 1997; Reilly et al. 1998) may be
useful. However, the levels of F2 isoprostanes or lipoper-
oxides and ascorbic acid are unlikely to correlate signif-
icantly, as once initiated the rate and extent of propagation
of peroxidation is related to various factors such as vitamin
E concentration and type and amount of fatty acids within
lipid structures (Benzie, 1996b).
Physiological markers
This type of marker relates to changes in homeostatic proc-
esses or organ and tissue function. However, cellular and
subcellular changes are generally well advanced before
detectable symptoms and measurable signs develop, and it is
difficult to isolate or identify one specific cause. None-
theless, identification of physiological markers is necessary
as molecular and biochemical effects are only as important
as their ultimate biological consequences.
There is strong and consistent epidemiological evidence
of a protective role for vitamin C against cancer of various
sites (Block, 1991; Machlin, 1995). Cancer is caused by
mutational changes in DNA, and vitamin C may help
prevent these changes by scavenging reactive oxygen
species. Measuring DNA oxidation products (Dizdaroglu,
1991) and assessing resistance of DNA to oxidative stress
(Duthie et al. 1996; Sweetman et al. 1997) may reflect
vitamin C action. However, DNA damage is unlikely to be a
specific marker of ascorbic acid status, and DNA repair may
mask or exaggerate indices of damage, depending on the
analytical method used.
Blood pressure is reported to show an inverse correlation
with vitamin C intake; endothelial function, haemostasis and
glucose homeostasis improve with increased vitamin C, and
atheromatous plaques may stabilize or regress with
improved antioxidant status (Paolisso et al. 1994; Bendich
Fig. 3. Deoxypyridinoline : total collagen cross-links in bone ( )
and urine (%) of guinea-pigs fed on different amounts of vitamin C.
Values are means with their standard errors represented by vertical
bars. Mean values for animals fed on adequate (0·1 g/kg diet) vitamin
C were significantly higher than those of animals fed on diets high
(30 g/kg diet) in vitamin C: *P < 0·05, **P < 0·001. (From Tsuchiya &
Bates, 1997.)
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& Langseth, 1995; Levine et al. 1996; Weber et al. 1996).
However, these physiological markers are affected by many
factors. Monitoring changes in response to changing vitamin
C intake could reveal useful information regarding vitamin
C-specific functions in relation to these systems and the way
in which vitamin C may modulate disease risk. However, a
single measurement of any of these physiological markers
cannot be regarded as a reliable functional marker of
vitamin C status.
Conclusion
In a complex system, small initial changes can lead to large
differences in outcome. This ‘butterfly effect’ which is
fundamental to mathematical chaos theory relates to vitamin
C status, as molecular changes and their ultimate con-
sequences are likely to have a critical and sensitive depend-
ence on initial conditions. Molecular changes are difficult to
measure, and their eventual outcome may be unknown or
highly speculative. However, molecular changes cause
larger and diverse effects in the prevailing biochemical
milieu. Effects become more easy to measure, but their spe-
cific origin becomes less clear, and their relevance to distant
events may remain obscure. The ultimate health-related
consequences may be obvious, but their cause is difficult to
trace.
Reliable functional markers will enable molecular,
biochemical and physiological changes associated with
differences in vitamin C status to be mapped. There are
currently no reliable functional markers of vitamin C status;
however, measurement of free carnitine and deoxypyridino-
line : total collagen cross-links appear promising. Assessing
the contribution of ascorbic acid to antioxidant defence
capacity, measuring ascorbate free radical : ascorbic acid,
and investigating oxidative damage to DNA and lipid may
also provide insight into the functional effects of vitamin C.
Available evidence suggests that intake of 200 mg vitamin
C/d saturates tissues and maintains fasting plasma levels
above the proposed threshold (50 µmol/l) for minimum risk
of CHD (Gey, 1995; Graumlich et al. 1997). The issue of
whether or not these produce ‘optimal vitamin C status’
awaits the clear and accepted definition of the term. This
definition in turn awaits the development of reliable func-
tional markers capable of assessing the effects of varying
levels of vitamin C nutriture.
References
Bailey AL, Maisey S, Southon S, Wright AJA, Finglas PM &
Fulcher RA (1997) Relationships between micronutrient intake
and biochemical indicators of nutrient adequacy in a ‘free-living’
elderly UK population. British Journal of Nutrition 77, 225–242.
Bates CJ (1977) Proline and hydroxyproline excretion and vitamin
C status in elderly human subjects. Clinical Science and
Molecular Medicine 52, 535–543.
Bates CJ (1997) Bioavailability of vitamin C. European Journal of
Clinical Nutrition 51, S28–S33.
Bates CJ, Bailey A, van der Berg H, van Schaik F, Coudray C,
Faviet A, Farré R, Frigola A, Heseker H, Maiani G, Ferro-Luzzi
A, Pietrzik K & Thurnham DI (1994) Plasma vitamin C assays:
a European experience. International Journal of Vitamin
Research 64, 283–287.
Bates CJ, Prynne CJ & Levene CI (1972) Ascorbate-dependent
differences in the hydroxylation of proline and lysine in
collagen synthesised by 3T6 fibroblasts in culture. Biochimica et
Biophysica Acta 278, 610–616.
Bendich A & Langseth L (1995) The health effects of vitamin C
supplementation. Journal of the American College of Nutrition
14, 124–136.
Benzie IFF (1996a) An automated, specific, spectrophotometric
method for measuring ascorbic acid in plasma (EFTSA). Clinical
Biochemistry 29, 111–116.
Benzie IFF (1996b) Lipid peroxidation: a review of
causes, consequences, measurement and dietary influences.
International Journal of Food Science and Nutrition 47, 233–
262.
Benzie IFF, Janus ED & Strain JJ (1998) Plasma ascorbate and
vitamin E levels in Hong Kong Chinese. European Journal of
Clinical Nutrition 52, 447–451.
Benzie IFF (1998) Antioxidants: observational epidemiology.
In The Encyclopedia of Nutrition, pp. 106–115 [M Sadler, B
Cabellero and JJ Strain, editors]. London: Academic Press.
Benzie IFF & Strain JJ (1996a) Uric acid – friend or foe. Redox
Report 2, 231–234.
Benzie IFF & Strain JJ (1996b) The reducing ability of plasma as a
measure of ‘antioxidant power’ – the FRAP assay. Analytical
Biochemistry 239, 70–76.
Benzie IFF & Strain JJ (1997a) Acute post-ingestion changes in
plasma ascorbic acid concentration: relationship to dose and to
existing body stores. Nutrition Research 17, 187–190.
Benzie IFF & Strain JJ (1997b) Simultaneous automated
measurement of total antioxidant (reducing) capacity and
ascorbic acid concentration. Redox Report 3, 233–238.
Blanchard J, Conrad KA, Mead RA & Garry PJ (1990) Vitamin C
disposition in young and elderly men. American Journal of
Clinical Nutrition 51, 837–845.
Blanchard J, Tozer TN & Rowland M (1997) Pharmacokinetic
perspectives on megadoses of ascorbic acid. American Journal of
Clinical Nutrition 66, 1165–1171.
Block G (1991) Vitamin C and cancer prevention: the
epidemiologic evidence. American Journal of Clinical Nutrition
53, 270S–282S.
Bluck JC, Izzard AP & Bates CJ (1996) Measurement of
ascorbate kinetics in man using stable isotopes and gas
chromatography mass spectrometry. Journal of Mass Spectrom-
etry 31, 741–748.
Buettner GR & Jurdkiewicz BA (1996) Catalytic metals, ascorbate
and free radicals; combinations to avoid. Radiation Research
145, 532–541.
Department of Health (1991) Dietary Reference Values for Food
Energy and Nutrients for the United Kingdom. Report on Health
and Social Subjects no. 41. London: H.M. Stationery Office.
Diplock AT (1994) Antioxidants and disease prevention.
Molecular Aspects of Medicine 15, 293–376.
Dizdaroglu M (1991) Chemical determination of free-radical-
induced damage to DNA. Free Radical Biology and Medicine
10, 225–242.
Duthie SJ, Ma A, Ross MA & Collins AR (1996) Antioxidant
supplementation decreases oxidative damage in human
lymphocytes. Cancer Research 56, 1291–1295.
Evans RM, Currie L & Campbell A (1982) The distribution of
ascorbic acid between various cellular components of blood, in
normal individuals, and its relation to the plasma concentration.
British Journal of Nutrition 47, 473–482.
Feller AG & Ridman D (1988) Role of carnitine in human nutrition.
Journal of Nutrition 118, 541–547.
Frei B, England L & Ames BN (1989) Ascorbate is an outstanding
antioxidant in human blood plasma. Proceedings of the National
Academy of Sciences USA 86, 6377–6381.
AMA PNS0024.fm  Page 474  Thursday, June 24, 1999  3:45 PM
Optimal nutrition 475
Frei B, Keaney JF, Retsky KL & Chen K (1996) Vitamin C and E
and LDL oxidation. Vitamins and Hormones – Advances in
Research and Applications 54, 1–34.
Garry PJ, VanderJagt DJ & Hunt WC (1987) Ascorbic acid intakes
and plasma levels in healthy elderly. Annals of the New York
Academy of Sciences 498, 90–99.
Gey KF (1995) Ten year retrospective on the antioxidant
hypothesis of arteriosclerosis: threshold plasma levels of
antioxidant nutrients related to minimum cardiovascular risk.
Journal of Nutritional Biochemistry 6, 206–236.
Ghosh MK, Mukhopadhyay M & Chatterjee IB (1997) NADPH-
initiated cytochrome P450-dependent free iron-independent
microsomal lipid peroxidation: specific prevention by ascorbic
acid. Molecular and Cellular Biochemistry 166, 35–44.
Ginter E (1989) Ascorbic acid in cholesterol metabolism and in
detoxification of xenobiotic substances: problem of optimum
vitamin C intake. Nutrition 5, 369–374.
Graumlich JF, Ludden TM, Conry-Cantilena C, Cantlena LR Jr,
Wang Y & Levine M (1997) Pharmacokinetic model of ascorbic
acid in healthy male volunteers during depletion and repletion.
Pharmaceutical Research 14, 1133–1139.
Halliwell B (1996) Oxidative stress, nutrition and health.
Experimental strategies for optimisation of nutritional anti-
oxidant intake in humans. Free Radical Research 25, 57–74.
Halliwell B (1997) Ascorbic acid: hype, hoax or healer? (Editorial).
American Journal of Clinical Nutrition 65, 1891–1892.
Hathcock JN (1997) Vitamins and minerals: efficacy and safety.
American Journal of Clinical Nutrition 66, 427–437.
Hemila H (1997) Vitamin C intake and the common cold. British
Journal of Nutrition 77, 59–72.
Hennekens CH, Buring JE & Peto R (1994) Antioxidant vitamins –
benefits not yet proved. New England Journal of Medicine 330,
1080–1081.
Hevia P, Omaye ST & Jacob RA (1990) Urinary hydroxyproline
excretion and vitamin C status in healthy young men. American
Journal of Clinical Nutrition 51, 644–648.
Hubel CA, Kagan VE, Kisin ER, McLauchlin MK & Roberts JM
(1997) Increased ascorbate radical formation and ascorbate
depletion in plasma from women with preeclampsia:
implications for oxidative stress. Free Radical Biology and
Medicine 4, 597–609.
Jackson MJ, McArdle A & McArdle F (1998) Antioxidant
micronutrients and gene expression. Proceedings of the Nutrition
Society 57, 301–305.
Jacob RA & Pianalto FS (1997) Urinary carnitine excretion
increases during experimental vitamin C depletion of healthy
men. Journal of Nutritional Biochemistry 8, 265–269.
Jacob RA, Skala JH & Omaye ST (1987) Biochemical indices of
human vitamin C status. American Journal of Clinical Nutrition
46, 818–826.
Johnston CS, Cartee GD & Haskell BE (1985) Effect of ascorbic
acid nutriture on protein-bound hydroxyproline in guinea pig
plasma. Journal of Nutrition 115, 1089–1093.
Johnston CS, Solomon E & Corte C (1996) Vitamin C depletion is
associated with alterations in blood histamine and plasma free
carnitine in adults. American Journal of Clinical Nutrition 15,
586–591.
Jung CH & Wells WW (1997) Ascorbic acid is a stimulatory
cofactor for mitochondrial glycerol-3-phosphate dehydrogenase.
Biochemical and Biophysical Research Communications 239,
457–462.
Kallner A, Hartmann D & Hornig DH (1981) On the requirement
of ascorbic acid in man: steady state turnover and body pool
in smokers. American Journal of Clinical Nutrition 34, 1347–
1355.
King J (1996) The need to consider functional endpoints in defining
nutrient requirements. American Journal of Clinical Nutrition
63, 983S–984S.
Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF & Vita
JA (1996) Ascorbic acid reverses endothelial vasomotor
dysfunction in patients with coronary artery disease. Circulation
93, 1107–1113.
Levine M (1986) New concepts in the biology and biochemistry of
ascorbic acid. New England Journal of Medicine 314, 892–902.
Levine M, Cantilena CC & Dhariwal KR (1993) In situ kinetics and
ascorbic acid requirements. World Review of Nutrition and
Dietetics 72, 114–127.
Levine M, Dhariwal KR, Welch RW, Wang Y & Park JB (1995)
Determination of optimal vitamin C requirements in humans.
American Journal of Clinical Nutrition 62, 1347S–1356S.
Levine M & Hartzell W (1987) Ascorbic acid: the concept of
optimum requirements. Annals of the New York Academy of
Sciences 498, 424–444.
Machlin LJ (1995) Critical assessment of the epidemiological data
concerning the impact of antioxidant nutrients on cancer and
cardiovascular disease. Critical Reviews in Food Science and
Nutrition 35, 41–50.
Makrigiorgos GM, Kassis AI, Mahmood A, Bump EA & Savvides
P (1997) Novel fluorescein-based flow-cytometric method for
detection of lipid peroxidation. Free Radical Biology and
Medicine 22, 93–100.
Marangon K, Herbeth B, Lecomte E, Paul-Dauphin A, Grolier P,
Chancerelle Y, Artur Y & Siest G (1998) Diet, antioxidants and
smoking habits in French men. American Journal of Clinical
Nutrition 67, 231–239.
Maxwell SRJ & Lip GYH (1997) Free radicals and antioxidants
in cardiovascular disease. British Journal of Clinical Pharma-
cology 44, 307–317.
Mayersohn M (1972) Ascorbic acid absorption in man –
pharmacokinetic implications. European Journal of Pharmacol-
ogy 19, 140–142.
Melethil S, Mason WD & Chang CJ (1986) Dose dependent
absorption and excretion of vitamin C in humans. International
Journal of Pharmaceuticals 31, 83–89.
Mendiratta S, Qu ZC & May JM (1998) Erythrocyte ascorbate
recycling: antioxidant effects in blood. Free Radical Biology and
Medicine 24, 789–797.
Ortega RM, Quintas ME, Andres P, Martinez RM & Lopez-Sobaler
AM (1998) Ascorbic acid levels in maternal milk: differences
with respect to ascorbic acid status during the third trimester of
pregnancy. British Journal of Nutrition 79, 431–437.
Padh H (1990) Cellular functions of ascorbic acid. Biochemistry
and Cell Biology 68, 1166–1173.
Paolisso G, D’Amore A, Balbi V, Volpe C, Galzerano D, Giugliano
D, Sgambato S, Varricchio M & D’Onofrio F (1994) Plasma
vitamin C affects glucose homeostasis in healthy subjects and
in non-insulin-dependent diabetics. Endocrinology and
Metabolism 29, E261–E268.
Reilly MP, Lawson JA & Fitzgerald GA (1998) Eicosanoids and
isoeicosanoids: indices of cellular function and oxidant stress.
Journal of Nutrition 128, 434S–438S.
Riemiersma RA (1994) Epidemiology and the role of antioxidants
in preventing coronary heart disease; a brief overview. Proceed-
ings of the Nutrition Society 57, 787S–797S.
Roberts LJ & Morrow JD (1994) Isoprostanes: novel markers of
endogenous lipid peroxidation and potential mediators of oxidant
injury. Annals of the New York Academy of Sciences 744, 237–
242.
Schorah CJ (1992) The transport of vitamin C and effects of
disease. Proceedings of the Nutrition Society 51, 189–192.
AMA PNS0024.fm  Page 475  Thursday, June 24, 1999  3:45 PM
476 I. F. F. Benzie
Shane B (1997) Vitamin C pharmacokinetics: it's deja vu all over
again (Editorial). American Journal of Clinical Nutrition 66,
1061–1062.
Smirnoff N & Pallanca JE (1996) Ascorbate metabolism in relation
to oxidative stress. Biochemical Society Transactions 24, 472–
478.
Steinberg D, Parthasarathy S, Carew TE, Khoo JC & Witzum JL
(1989) Beyond cholesterol; modifications of low-density
lipoprotein that increase its atherogenicity. New England Journal
of Medicine 320, 915–924.
Strain JJ & Benzie IFF (1998) Antioxidant nutrients. In Functional
Foods; the Consumer, the Products and the Evidence, pp 74–79
[MJ Sadler and M Saltmarsh, editors]. Cambridge: Royal Society
of Chemistry.
Sweetman SF, Strain JJ & McKelvey Martin V (1997) Effect of
antioxidant vitamin supplementation on DNA damage and repair
in human lymphoblastoid cell. Nutrition and Cancer 27, 122–
130.
Swille PO, Schmiedl A, Herrmann U & Wipplinger J (1997)
Postprandial hyperinsulinaemia, insulin resistance and
inappropriately high phosphaturia are features of younger males
with idiopathic calcium urolithiasis: attenuation by ascorbic acid
supplementation of a test meal. Urology Research 25, 49–58.
Tsuchiya H & Bates CJ (1997) Vitamin C and copper interactions
in guinea-pigs and a study of collagen cross-links. British
Journal of Nutrition 77, 315–325.
Wayner DDM, Burton GW, Ingold KU, Barclay LRC & Locke SJ
(1987) The relative contributions of vitamin E, urate, ascorbate
and proteins to the total peroxyl radical-trapping antioxidant
activity of human blood plasma. Biochimica et Biophysica Acta
924, 408–419.
Weber P, Bendich A & Schalch W (1996) Vitamin C and human
health – a review of recent data relevant to human requirements.
International Journal of Vitamin and Nutrition Research 66, 19–
30.
Young V (1996) Evidence for a recommended dietary allowance
for vitamin C from pharmacokinetics; a comment and analysis.
Proceedings of the National Academy of Sciences USA 93, 1433–
1438.
© Nutrition Society 1999
AMA PNS0024.fm  Page 476  Thursday, June 24, 1999  3:45 PM
